CAS No. |
223595-20-8 |
中文名称 |
(1R)-2,3-二氢-1-甲基-5-(四氢-4H-1,3,6,2-二氧杂氮杂硼杂辛环-2-基)-2-(三苯甲基)-1H-异吲哚 |
英文名称 |
2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole |
别名 |
2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole;(1R)-2,3-Dihydro-1-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole;(R)-5-(1,3,6,2-Dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline;2-((1R)-1-Methyl-2-trityl-2,3-dihydro-1H-isoindol-5-yl)-1,3,6,2-dioxazaborocane;(R)-2-(1-methyl-2-tritylisoindolin-5-yl)-1,3,6,2-dioxazaborocane;(R)-2-(1-methyl-2-tritylisoindolin-5-yl)-1,3,6,2-dioxazaborocane 2-[(1R)-1-;2-[2-[2-(diphenylmethyl)phenyl]-1-methyl-1,3-dihydroisoindol-5-yl]-1,3,6,2-dioxazaborocane;(R)-5-(1,3,6,2-Dioxazaborocan-2-yl)-1-methyl-2-tritylisoindo... |
标准英文名 |
(R)-2-(1-methyl-2-tritylisoindolin-5-yl)-1,3,6,2-dioxazaborocane |
MDL No. |
MFCD09751017 |
分子式 |
C32H33BN2O2 |
分子量 |
488.44
|
精确分子量 |
488.26
|
SMILES |
C[C@H]1N(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)CC5=C1C=CC(B6OCCNCCO6)=C5 |
标准SMILES |
C[C@@H]1C2C=CC(=CC=2CN1C(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)B1OCCNCCO1 |
用途 |
Garenoxacin mesylate is a fourth-generation quinolone antibiotic developed by Toyama Chemical Co., Ltd., used for the treatment of infections caused by both Gram-positive and Gram-negative bacteria. It is indicated for the treatment of surgical and respiratory tract infections and can be administered orally or by injection. The compound exerts its bactericidal effect by inhibiting bacterial DNA gyrase and topoisomerase IV, and it selectively inhibits bacterial topoisomerase II (TopII). |
InChIKey |
RQCOQFKQRXOKEP-RUZDIDTESA-N |